 Connection
Ernesto Sparrelid to Portal Vein
This is a "connection" page, showing publications Ernesto Sparrelid has written about Portal Vein.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
5.041 |
|
|
|
-
Wang Q, Brismar TB, Bj?rk D, Baubeta E, Lindell G, Bj?rnsson B, Sparrelid E. Development and External Validation of a Combined Clinical-Radiomic Model for Predicting Insufficient Hypertrophy of the Future Liver Remnant following Portal Vein Embolization. Ann Surg Oncol. 2025 Mar; 32(3):1795-1807.
Score: 0.857
-
Bj?rnsson B, Hasselgren K, R?sok B, Larsen PN, Urdzik J, Schultz NA, Carling U, Fallentin E, Gilg S, Sandstr?m P, Lindell G, Sparrelid E. Segment 4 occlusion in portal vein embolization increase future liver remnant hypertrophy - A Scandinavian cohort study. Int J Surg. 2020 Mar; 75:60-65.
Score: 0.612
-
Sparrelid E, Johansson H, Gilg S, Nowak G, Ellis E, Isaksson B. Serial Assessment of Growth Factors Associated with Liver Regeneration in Patients Operated with Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy. Eur Surg Res. 2018; 59(1-2):72-82.
Score: 0.542
-
Sparrelid E. Reply to "Comment to Sparrelid, E. et al. Dynamic Evaluation of Liver Volume and Function in Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy. Journal of Gastrointestinal Surgery (2017)". J Gastrointest Surg. 2017 10; 21(10):1756.
Score: 0.514
-
Sparrelid E, Jonas E, Tzortzakakis A, Dahl?n U, Murquist G, Brismar T, Axelsson R, Isaksson B. Dynamic Evaluation of Liver Volume and Function in Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy. J Gastrointest Surg. 2017 06; 21(6):967-974.
Score: 0.501
-
Sparrelid E, Gilg S, Brismar TB, Lundell L, Isaksson B. Rescue ALPPS is efficient and safe after failed portal vein occlusion in patients with colorectal liver metastases. Langenbecks Arch Surg. 2017 Feb; 402(1):69-75.
Score: 0.487
-
Oba A, Tanaka K, Inoue Y, Valente R, Rangelova E, Arnelo U, Ono Y, Sato T, Torphy RJ, Ito H, L?hr M, Takahashi Y, Schulick RD, Saiura A, Sparrelid E, Del Chiaro M. Pancreatectomies with vein resection: Two large institutions' experience of East and West. Pancreatology. 2025 Mar; 25(2):250-257.
Score: 0.216
-
Hasselgren K, R?sok BI, Larsen PN, Sparrelid E, Lindell G, Schultz NA, Bj?rnbeth BA, Isaksson B, Larsson AL, Rizell M, Bj?rnsson B, Sandstr?m P. Response to Comment on: Hasselgren K, et al ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021;273(3):442-448. Ann Surg. 2022 11 01; 276(5):e632-e633.
Score: 0.172
-
Olthof PB, Aldrighetti L, Alikhanov R, Cescon M, Groot Koerkamp B, Jarnagin WR, Nadalin S, Pratschke J, Schmelze M, Sparrelid E, Lang H, Guglielmi A, van Gulik TM. Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma. Ann Surg Oncol. 2020 Jul; 27(7):2311-2318.
Score: 0.154
-
Hasselgren K, Sandstr?m P, R?sok BI, Sparrelid E, Lindell G, Larsen PN, Larsson AL, Schultz NA, Bj?rnbeth BA, Isaksson B, Rizell M, Bj?rnsson B. Future Liver Remnant (FLR) Increase in Patients with Colorectal Liver Metastases Is Highest the First Week After Portal Vein Occlusion : FLR Increase in Patients with CRLM Is Highest the First Week After PVO. J Gastrointest Surg. 2019 03; 23(3):556-562.
Score: 0.141
-
Bj?rnsson B, Sparrelid E, Hasselgren K, Gasslander T, Isaksson B, Sandstr?m P. Associating Liver Partition and Portal Vein Ligation for Primary Hepatobiliary Malignancies and Non-Colorectal Liver Metastases. Scand J Surg. 2016 Sep; 105(3):158-62.
Score: 0.117
-
Bj?rnsson B, Sparrelid E, R?sok B, Pomianowska E, Hasselgren K, Gasslander T, Bj?rnbeth BA, Isaksson B, Sandstr?m P. Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results. Eur J Surg Oncol. 2016 Apr; 42(4):531-7.
Score: 0.116
-
R?sok BI, Bj?rnsson B, Sparrelid E, Hasselgren K, Pomianowska E, Gasslander T, Bj?rnbeth BA, Isaksson B, Sandstr?m P. Scandinavian multicenter study on the safety and feasibility of the associating liver partition and portal vein ligation for staged hepatectomy procedure. Surgery. 2016 May; 159(5):1279-86.
Score: 0.114
-
Spelt L, Sparrelid E, Isaksson B, Andersson RG, Sturesson C. Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases. HPB (Oxford). 2015 Jun; 17(6):529-35.
Score: 0.109
-
Korenblik R, Olij B, Aldrighetti LA, Hilal MA, Ahle M, Arslan B, van Baardewijk LJ, Baclija I, Bent C, Bertrand CL, Bj?rnsson B, de Boer MT, de Boer SW, Bokkers RPH, Rinkes IHMB, Breitenstein S, Bruijnen RCG, Bruners P, B?chler MW, Camacho JC, Cappelli A, Carling U, Chan BKY, Chang DH, Choi J, Font JC, Crawford M, Croagh D, Cugat E, Davis R, De Boo DW, De Cobelli F, De Wispelaere JF, van Delden OM, Delle M, Detry O, D?az-Nieto R, Dili A, Erdmann JI, Fisher O, Fondevila C, Fretland ?, Borobia FG, Gelabert A, G?rard L, Giuliante F, Gobardhan PD, G?mez F, Gr?nberger T, Gr?nhagen DJ, Guitart J, Hagendoorn J, Heil J, Heise D, Herrero E, Hess GF, Hoffmann MH, Iezzi R, Imani F, Nguyen J, Jovine E, Kalff JC, Kazemier G, Kingham TP, Kleeff J, Kollmar O, Leclercq WKG, Ben SL, Lucidi V, MacDonald A, Madoff DC, Manekeller S, Martel G, Mehrabi A, Mehrzad H, Meijerink MR, Menon K, Metrakos P, Meyer C, Moelker A, Modi S, Montanari N, Navines J, Neumann UP, Peddu P, Primrose JN, Qu X, Raptis D, Ratti F, Ridouani F, Rogan C, Ronellenfitsch U, Ryan S, Sallemi C, Moragues JS, Sandstr?m P, Sarri? L, Schnitzbauer A, Serenari M, Serrablo A, Smits MLJ, Sparrelid E, Sp?ntrup E, Stavrou GA, Sutcliffe RP, Tancredi I, Tasse JC, Udupa V, Valenti D, Fundora Y, Vogl TJ, Wang X, White SA, Wohlgemuth WA, Yu D, Zijlstra IAJ, Binkert CA, Bemelmans MHA, van der Leij C, Schadde E, van Dam RM. Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy. Cardiovasc Intervent Radiol. 2022 09; 45(9):1391-1398.
Score: 0.045
-
Hasselgren K, R?sok BI, Larsen PN, Sparrelid E, Lindell G, Schultz NA, Bj?rnbeth BA, Isaksson B, Larsson AL, Rizell M, Bj?rnsson B, Sandstr?m P. Response to the Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO-Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy". Ann Surg. 2021 12 01; 274(6):e750-e751.
Score: 0.043
-
Heil J, Heid F, Bechstein WO, Bj?rnsson B, Brismar TB, Carling U, Erdmann J, Fretland ?A, Grunhagen D, Hana RA, Hohmann J, Linke R, Meyer Y, Nawawi A, Olthof PB, Sandstr?m P, Schnitzbauer AA, Sparrelid E, Verhoef C, Metrakos P, Schadde E. Sarcopenia predicts reduced liver growth and reduced resectability in patients undergoing portal vein embolization before liver resection - A DRAGON collaborative analysis of 306 patients. HPB (Oxford). 2022 03; 24(3):413-421.
Score: 0.043
-
Wang Q, Chen S, Yan J, Brismar T, Sparrelid E, Qu C, Ji Y, Chen S, Ma K. Rescue radiofrequency ablation or percutaneous ethanol injection: a strategy for failed RALPPS stage-1 in patients with cirrhosis-related hepatocellular carcinoma. BMC Surg. 2021 May 18; 21(1):246.
Score: 0.042
-
Hasselgren K, R?sok BI, Larsen PN, Sparrelid E, Lindell G, Schultz NA, Bj?rnbeth BA, Isaksson B, Larsson AL, Rizell M, Bj?rnsson B, Sandstr?m P. ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021 03 01; 273(3):442-448.
Score: 0.041
-
Tomassini F, D'Asseler Y, Linecker M, Giglio MC, Castro-Benitez C, Truant S, Axelsson R, Olthof PB, Montalti R, Serenari M, Chapelle T, Lucidi V, Sparrelid E, Adam R, Van Gulik T, Pruvot FR, Clavien PA, Bruzzese D, Geboes K, Troisi RI. Hepatobiliary scintigraphy and kinetic growth rate predict liver failure after ALPPS: a multi-institutional study. HPB (Oxford). 2020 10; 22(10):1420-1428.
Score: 0.038
-
Sandstr?m P, R?sok BI, Sparrelid E, Lindell G, N?rgaard Larsen P, Lindhoff Larsson A, Schultz NA, Bj?rnbeth BA, Isaksson B, Rizell M, Bj?rnsson B. Response to the Comment on "Should We Have a Little More Patience With the Conventional 2-Stage Hepatectomy?" Ann Surg. 2019 03; 269(3):e33-e34.
Score: 0.036
-
Sandstr?m P, R?sok BI, Sparrelid E, Larsen PN, Larsson AL, Lindell G, Schultz NA, Bj?rnbeth BA, Isaksson B, Rizell M, Bj?rnsson B. Response to "ALPPS Versus Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastases". Ann Surg. 2019 01; 269(1):e16-e17.
Score: 0.035
-
Sanjeevi S, Sparrelid E, Gilg S, Jonas E, Isaksson B. High incidence of biliary stricture after associating liver partition and portal vein ligation for staged hepatectomy. ANZ J Surg. 2018 Jul-Aug; 88(7-8):760-764.
Score: 0.033
-
Olthof PB, Tomassini F, Huespe PE, Truant S, Pruvot FR, Troisi RI, Castro C, Schadde E, Axelsson R, Sparrelid E, Bennink RJ, Adam R, van Gulik TM, de Santibanes E. Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: Liver volume overestimates liver function. Surgery. 2017 10; 162(4):775-783.
Score: 0.032
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|